Related Experiment Video
Updated: Dec 21, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen
Roger Dodd1, Darren J Schofield1, Trevor Wilkinson1
1Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
Abstract:
Complex integral membrane proteins, which are embedded in the cell surface lipid bilayer by multiple transmembrane spanning helices, encompass families of proteins which are important target classes for drug discovery. These protein families include G protein-coupled receptors, ion channels and transporters. Although these proteins have typically been targeted by small molecule drugs and peptides, the high specificity of monoclonal antibodies offers a significant opportunity to selectively modulate these target proteins. However, it remains the case that isolation of antibodies with desired pharmacological function(s) has proven difficult due to technical challenges in preparing membrane protein antigens suitable to support antibody drug discovery. In this review recent progress in defining strategies for generation of membrane protein antigens is outlined. We also highlight antibody isolation strategies which have generated antibodies which bind the membrane protein and modulate the protein function.
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

